Synthetic Biology for Engineering Applications (R01 Clinical Trial Optional)

Funding Agency:
National Institutes of Health

This Funding Opportunity Announcement (FOA) invites applications to conduct research to advance the understanding and application of synthetic biology for human health. It will support 1) the development of innovative tools and technologies in synthetic biology and 2) their application in biomedical research and human health. An integrative research plan based on collaborations of synthetic biologists with computational scientists, cell biologists, engineers, and/or physician scientists is strongly recommended. Early Stage Investigators in Synthetic Biology are especially encouraged to apply.


  • R01 Due Dates: Feb. 5, Jun. 5, Oct. 5
  • AIDS Due Dates: Jan. 7, May 7, Sep. 7

PAR-18-434 Expiration Date New Date January 8, 2021 per issuance of NOT-EB-20-010. (Original Expiration Date: September 8, 2020 )

Agency Website

Amount Description

Projects are limited to $1,500,000 per year in direct costs but total cost cannot exceed $2,250,000 per year. The maximum period is 5 years. 

Funding Type





Engineering and Physical Sciences
Environmental & Life Sciences
Medical - Basic Science
Medical - Clinical Science
Medical - Translational

External Deadline

October 5, 2020